Mapping of cortical metabolic activation in soman-induced convulsions in rats

Brain Research Bulletin

Volumn 43, Issue 4, 1997, Pages 425-434

  Scremin, Oscar U ^a,b,c   Shih, Tsung Ming ^a,b   Li, Mingen G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b US Army Med Res Inst Chem   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Autoradiography; Brain lesions; Cerebral glucose utilization; Convulsions; Organophosphate cholinesterase inhibitors; Pyridostigmine; Rat; Soman

Indexed keywords

CHOLINESTERASE INHIBITOR; GLUCOSE; ORGANOPHOSPHORUS COMPOUND; PYRIDOSTIGMINE; SODIUM CHLORIDE; SOMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN MAPPING; BRAIN METABOLISM; CONTROLLED STUDY; CONVULSION; GLUCOSE UTILIZATION; MALE; METABOLIC ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN MAPPING; CEREBRAL CORTEX; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; SOMAN;

EID: 0030752533     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(97)00029-4     Document Type: Article

References (40)

1. Bataillard A., Sannajust F., Yoccoz D., Blanchet G., Sentenac-Roumanou H., Sassard J. Cardiovascular consequences of organophosphorus poisoning and of antidotes in conscious unrestrained rats. Pharmacol. Toxicol. 67:1990;27-35.
2. Berry W. K., Davies D. R. The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate. Biochem. Pharmacol. 19:1970;927-934.
3. Brown A. W., Brierley J. B. The nature, distribution and earliest stages of anoxic-ischaemic nerve cell damage in the rat brain as defined by the optical microscope. Br. J. Exp. Pathol. 49:1968;87-106.
4. Cechetto D. F., Chen S. J. Hypothalamic and cortical sympathetic responses relay in the medulla of the rat. Am. J. Physiol. 263:1992;R544-R552.
5. Cechetto D. F., Wilson J. X., Smith K. E., Wolski D., Silver M. D., Hachinski V. C. Autonomic and myocardial changes in middle cerebral artery occlusion: Stroke models in the rat. Brain Res. 502:1989;296-305.
6. Churchill L., Pazdernik T. L., Jackson J. L., Nelson S. R., Samson F. E., McDonough J. H. Jr., McLeod C. G. Jr. Soman-induced brain lesions demonstrated by muscarinic receptor autoradiography. Neurotoxicology. 6:1985;81-90.
7. Collins R. C., Kennedy C., Sokoloff L., Plum F. Metabolic anatomy of focal motor seizures. Arch. Neurol. 33:1976;536-542.
8. Dirnhuber P., French M. C., Green D. M., Leadbeater L., Stratton J. A. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J. Pharm. Pharmacol. 31:1979;295-299.
9. Engel J. Jr., Ackermann R. F., Kuhl D. E., Phelps M. E. Brain imaging of glucose utilization in convulsive disorders. Sokoloff L. Brain imaging and brain function. 1985;163-186 Raven Press, New York.
10. Gordon J. J., Leadbeater L., Maidment M. P. The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol. Appl. Pharmacol. 43:1978;207-216.
11. Groff W. A., Kaminskis A., Ellin R. I. Interconversion of cholinesterase enzyme activity units by the manual pH method and a recommended automated method. Clin. Toxicol. 9:1976;353-358.
12. 14C-2-deoxyglucose method. Brain Res. Rev. 20:1995;1-23.
13. 14C-2-deoxyglucose study in the lithium-pilocarpine model in the rat. Neuroscience. 64:1995;1057-1073.
14. Heyl W. C., Harris J. W., Stitcher D. L. Effects of carbamates on whole blood cholinesterase activity: Chemical protection against soman. Drug Chem. Toxicol. 3:1980;319-332.
15. Ingvar M., Folbergrová J., Siesjö N, B. K. Metabolic alterations underlying the development of hypermetabolic necrosis in the substantia nigra in status epilepticus. J. Cereb. Blood Flow Metab. 7:1987;103-108.
16. Kadar T., Cohen G., Sahar R., Alkalai D., Shapira S. Long-term study of brain lesions following soman, in comparison to DFP and metrazol poisoning. Hum. Exp. Toxicol. 11:1992;517-523.
17. Kato M., Malamut B. L., Caveness W. F., Hosokawa S., Wakisaka S., O'Neill R. R. Local cerebral glucose utilization in newborn and pubescent monkeys during focal motor seizures. Ann. Neurol. 7:1980;204-212.
18. Keeler J. R., Hurst C. G., Dunn M. A. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA. 266:1991;693-695.
19. 14C]-deoxyglucose technique. Science. 204:1979;641-643.
20. Kluwe W. M., Chinn J. C., Feder P., Olson C., Joiner R. Efficacy of pyridostigmine pretreatment against acute soman intoxication in a primate model. Proc. Sixth Med. Chem. Defense Biosci. Rev. 1987;227-234.
21. Koster R. Synergisms and antagonisms between physostigmine and diisopropylfluorphosphate in cats. J. Pharm. Pharmacol. 88:1946;38-46.
22. Lemercier G., Carpentier P., Sentenac-Roumanou H., Morelis P. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol. (Berl.). 61:1983;123-129.
23. Lennox W. J., Harris L. W., Talbot B. G., Anderson D. R. Relationship between reversible AChE inhibition and efficacy against soman lethality. Life. Sci. 37:1985;793-798.
24. McDonough J. H., Dochterman L. W., Smith C. D., Shih T.-M. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology. 15:1995;123-132.
25. McDonough J. H., Shih T.-M. Pharmacological modulation of soman-induced seizures. Neurosci. Biobehav. Rev. 17:1993;203-215.
26. McDonough J. H. Jr., Hackley B. E. Jr., Cross R. S., Samson F. E., Nelson S. R. Brain regional glucose use during soman-induced seizures. Neurotoxicology. 4:1983;203-210.
27. McLeod C. G. Jr. Pathology of nerve agents: Perspectives on medical management. Fundam. Appl. Toxicol. 5:1985;S10-S16.
28. McLeod C. G. Jr., Singer A. W., Harrington D. G. Acute neuropathology in soman poisoned rats. Neurotoxicology. 5:1984;53-58.
29. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, Sydney.
30. Pazdernik T. L., Cross R., Giesler M. P., Nelson S. G., Samson F. E., McDonough J. H. Jr. Delayed effects of soman: Brain glucose use and pathology. Neurotoxicology. 6:1985;61-70.
31. Petras J. M. Soman neurotoxicity. Fundam. Appl. Toxicol. 1:1981;242.
32. Phelps M. E., Mazziotta J. C., Huang S. C. Study of cerebral function with positron computed tomography. J. Cereb. Blood Flow Metab. 2:1982;113-162.
33. Ruggiero D. A., Mraovitch S., Granata A. R., Anwar M., Reis D. J. A role of insular cortex in cardiovascular function. J. Comp. Neurol. 257:1987;189-207.
34. Samson F. E., Pazdernik T. L., Cross R. S., Giesler M. P., Mewes K., Nelson S. R., McDonough J. H. Jr. Soman induced changes in brain regional glucose use. Fundam. Appl. Toxicol. 4:1984;S173-S183.
35. Sharabi Y., Danon Y. L., Berkenstadt H., Almog S., Mimouni-Bloch A., Zisman A. Survey of symptoms following intake of pyridostigmine during the Persian Gulf war. Brain Res. Rev. 20:1991;1-23.
36. Shih T.-M., Koviak T. A., Capacio B. R. Anticonvulsants for poisoning by the organophosphorus compound soman: Pharmacological mechanisms. Neurosci. Biobehav. Rev. 15:1991;349-362.
37. Shih T.-M., Scremin O. U. Cerebral blood flow and metabolism in soman-induced convulsions. Brain Res. Bull. 28:1992;735-742.
38. Siesjö B. K., Ingvar M., Folbergrová J., Chapman A. G. Local cerebral circulation in bicuculline-induced status epilepticus: Relevance for development of cell damage. Neurology. 34:1983;217-230.
39. 14]C-deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized normal rat. J. Neurochem. 28:1977;897-916.
40. Wasterlain C. G. Epileptic seizures. Siegel G. J., Agranoff B. W., Albers R. W., Molinoff P. Basic neurochemistry. 1989;797-810 Raven Press, New York.